HI
ABBV icon

Humankind Investments’s AbbVie ABBV Stock Holding History

Humankind Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,786
Closed -$3.89M – 20
2025
Q3 		$3.89M Sell
16,786
-1,298
-7% -$264K 0.89% 17
2025
Q2 		$3.36M Buy
18,084
+2,893
+19% +$538K 0.82% 19
2025
Q1 		$3.18M Sell
15,191
-3,132
-17% -$609K 0.83% 17
2024
Q4 		$3.26M Buy
18,323
+3,316
+22% +$610K 0.82% 19
2024
Q3 		$2.96M Sell
15,007
-1,292
-8% -$241K 1.07% 14
2024
Q2 		$2.8M Buy
16,299
+2,182
+15% +$361K 0.74% 20
2024
Q1 		$2.57M Sell
14,117
-2,575
-15% -$444K 0.68% 28
2023
Q4 		$2.59M Buy
16,692
+1,205
+8% +$176K 0.77% 22
2023
Q3 		$2.31M Sell
15,487
-617
-4% -$90.6K 0.96% 16
2023
Q2 		$2.17M Buy
16,104
+1,715
+12% +$251K 0.85% 19
2023
Q1 		$2.29M Buy
14,389
+491
+4% +$75.1K 0.95% 16
2022
Q4 		$2.25M Sell
13,898
-1,321
-9% -$203K 0.97% 16
2022
Q3 		$2.04M Buy
15,219
+3,168
+26% +$455K 0.99% 18
2022
Q2 		$1.85M Buy
12,051
+1,190
+11% +$182K 0.88% 17
2022
Q1 		$1.76M Sell
10,861
-2,088
-16% -$303K 0.72% 22
2021
Q4 		$1.75M Buy
12,949
+1,560
+14% +$184K 2.21% 11
2021
Q3 		$1.23M Buy
11,389
+2,282
+25% +$261K 1.87% 12
2021
Q2 		$1.03M Buy
9,107
+3,146
+53% +$354K 1.83% 16
2021
Q1 		$645K Buy
+5,961
New +$638K 1.98% 18

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Humankind Investments's ABBV Position: Q4 2025 in Review

Humankind Investments sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 16,786 shares — an estimated $3.89M sold.

Humankind Investments first reported a position in ABBV in Q1 2021 and held it in 19 quarters. The position peaked at $3.89M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Humankind Investments reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 16,786 AbbVie shares in Q4 2025, an estimated $3.89M.
  • Humankind Investments first reported a position in AbbVie in Q1 2021 and held it in 19 quarters.
  • Humankind Investments's AbbVie position peaked at $3.89M in Q3 2025.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.